Mastery EAQ Ch. 13

A  Onset after the age 7 years. Learning disability with signs of depression. Acting out during school or in the home

B  Symptoms lasting at least 6 months. Learning disability with signs of depression. Acting out during school or in the home

C  Onset after the age 7 years. Short attention span for the child’s age. Acting out during school or in the home

D  Lack of ability to control impulses. Symptoms lasting at least 6 months. Short attention span for the child’s age

A  Vital signs

B  Activity level

C  Pain status

D  Dietary intake

A  Respiratory rate of 16 breaths per minute

B  Carbon dioxide arterial blood gas levels increase

C  Responds to command to use incentive spirometer

D  Pulse of 98 beats per minute

A  Serotonin syndrome

B  Hangover effect

C  Rebound headache

D  Caffeine withdrawal

A  Onset of confusion, Slurred speech, Blood pressure of 168/94 mmHg, Two previous sumatriptan injections at 0800 and 1200

B  Onset of confusion, History of chronic headache, Blood pressure of 168/94 mmHg, Two previous sumatriptan injections at 0800 and 1200

C  Onset of confusion, Slurred speech, Blood pressure of 168/94 mmHg, History of chronic headache

D  Onset of confusion, Slurred speech, History of chronic headache, Two previous sumatriptan injections at 0800 and 1200

A  Schedule I

B  Schedule IV

C  Schedule II

D  Schedule III

A  Morphine

B  Diazepam

C  Phenobarbitone

D  Caffeine

A  Mood swings

B  Sleeplessness

C  Suicidal tendencies

D  Addiction

A  Caffeine

B  Sumatriptan

C  Orlistat

D  Atomoxetine

A  Dextroamphetamine sulfate

B  Amphetamine aspartate

C  Atomoxetine

D  Methylphenidate

A  Bronchopulmonary dysplasia and Migraines

B  Postanesthetic respiratory depression and Migraines

C  End-stage heart failure and Peptic ulcer disease

D  Postanesthetic respiratory depression and Bronchopulmonary dysplasia

A  Promotes constriction of the bronchi. Blocks the action of cerebral adenosine. Increases the production of surfactant.

B  Promotes constriction of the bronchi. Increases the production of surfactant. Increases sensitivity to carbon dioxide.

C  Relaxes the bronchial smooth muscle. Promotes constriction of the bronchi. Increases the production of surfactant.

D  Relaxes the bronchial smooth muscle. Increases sensitivity to carbon dioxide. Supports a regular pattern of breathing. Blocks the action of cerebral adenosine.

A  Atomoxetine for attention-deficit/hyperactivity disorder

B  Dextroamphetamine for narcolepsy

C  Modafinil for shift work sleep disorder

D  Orlistat for weight loss management

A  Early afternoon when restlessness occurs

B  Before breakfast on weekdays

C  Preceding morning school activities daily

D  At least 4 hours before bedtime

A  Take the medication with an antacid.

B  Supplement the diet with fat-soluble vitamins.

C  Increase fluid and fiber in the diet.

D  Limit dietary intake of fat to less than 30% of total calories.

A  Phentermine

B  Orlistat

C  Modafinil

D  Naratriptan

A  Take the medication with a lot of fluids.

B  Do not take phentermine.

C  Take ice chips for relief of headache.

D  Take acetaminophen.

A  Armodafinil

B  Amphetamine aspartate

C  Orlistat

D  Methylphenidate

A  Respiratory therapy

B  Dietary referral

C  Substance abuse treatment

D  Pain management

A  Talk to the health care provider about instituting “drug holidays.”

B  Switch the child to caffeine, which is a more natural stimulant.

C  Reduce the dose of the medication slightly.

D  Use deep breathing exercises instead of medication to keep the child calm.

A  “This is the normal behavior of a 7-year-old child.”

B  “You should consult a child psychiatrist immediately.”

C  “You should continue to observe the child’s behavior for 4 months.”

D  “Your child has attention-deficit/hyperactivity disorder.”

A  “You should drink coffee and alcohol once a week to reduce obesity.”

B  “Ask the primary health care provider to prescribe an anorexiant because it will reduce obesity.”

C  “Ask the primary health care provider to prescribe an oral hypoglycemic medication.”

D  “You should follow a nutrition and exercise regimen for weight management.”

A  The patient has taken the medication with excess amounts of fluids.

B  The patient has been taking reduced doses of medication.

C  The patient has not followed the dosing schedule as prescribed.

D  The patient has been taking this medication for a long time.

A  Benzphetamine

B  Orlistat

C  Phentermine

D  Methamphetamine

A  “This drug causes hallucinations.”

B  “This drug has a high risk of abuse.”

C  “This drug has many side effects.”

D  “This drug causes amenorrhea.”

A  Modafinil

B  Benzphetamine

C  Atomoxetine

D  Methylphenidate

A  Almotriptan

B  Caffeine

C  Phentermine

D  Dextroamphetamine

A  Modafinil and doxapram

B  Doxapram and sumatriptan

C  Modafinil and sumatriptan

D  Atomoxetine and orlistat

A  Avoid dissolving the sustained-release medications in water. Administer the medication after meals. Administer the medication 2 hours before going to bed.

B  Avoid administering medications on weekends. Avoid dissolving the sustained-release medications in water. Administer the medication before sending the child to school.

C  Administer the medication after meals. Administer the medication 2 hours before going to bed. Avoid administering medications on weekends.

D  Administer the medication after meals. Administer the medication before sending the child to school. Administer the medication 2 hours before going to bed.

A  “I will give these drugs 30 to 45 minutes before meals to improve absorption.”

B  “It is permissible to crush extended-release medications for patients who have difficulty swallowing pills.”

C  “If I notice side effects of these medications, I should stop giving the drug immediately and notify the provider.”

D  “I may dispense these medications to nursing staff if needed.”

A  Chest congestion

B  Diarrhea

C  Enhanced urinary output

D  Fecal incontinence

A  Diazepam and Ergotamine

B  Diazepam and Atomoxetine

C  Naratriptan and Zolmitriptan

D  Ergotamine and Sibutramine

A  The patient is taking monoamine oxidase inhibitors (MAOIs).

B  The patient has glaucoma.

C  The patient is taking antiviral medications.

D  The patient has diabetes.

A  Bradycardia

B  Insomnia

C  Decreased mental alertness

D  Hypotension

A  Syncope

B  Bradycardia

C  Drowsiness

D  Increased blood pressure

A  Tingling, Flushing, Numbness

B  Tingling, Dizziness, Flushing

C  Nasal irritation, Tingling, Flushing

D  Dizziness, Numbness, Nasal irritation

A  Gastric ulcers

B  Hyperglycemia

C  Insomnia

D  Nutrition deficiency

A  Dexmethylphenidate has more addictive properties.

B  Dexmethylphenidate does not improve attention.

C  Dexmethylphenidate is contraindicated in pediatric patients.

D  Dexmethylphenidate induces sedation in the child.

A  Photophobia, Phonophobia, Pulsating headache

B  Pulsating headache, Daytime sleepiness, Skeletal muscle weakness

C  Daytime sleepiness, Photophobia, Skeletal muscle weakness

D  Phonophobia, Daytime sleepiness, Skeletal muscle weakness

A  Headache, Increased appetite, Decreased blood pressure

B  Insomnia, Headache, Weight loss

C  Weight loss, Increased appetite, Decreased blood pressure

D  Increased appetite, Insomnia, Decreased blood pressure

A  Headache, Severe hypertension

B  Headache, Severe hypertension

C  Headache, Severe hypertension

D  Seizures, Insomnia, Dysrhythmias

A  Drug allergies, Hypotension, Hypothyroidism

B  Glaucoma, Drug allergies, Bulimia nervosa

C  Hypotension, Hypothyroidism, Glaucoma

D  Hypotension, Bulimia nervosa, Hypothyroidism

A  “I should not take these medications at least 1 day per week.”

B  “They block the reuptake of dopamine.”

C  “They increase the effect of norepinephrine.”

D  “It may decrease my heart rate.”

A  5 mg before breakfast and lunch

B  120 mg at each meal

C  20 mg after lunch

D  50 mg as a single dose

A  Sumatriptan

B  Dextroamphetamine

C  Orlistat

D  Modafinil

A  Phosphodiesterase inhibitors

B  Serotonin receptor agonists

C  Lipase inhibitors

D  Ergot alkaloids

A  Cerebrovascular system

B  Hypothalamic and limbic regions

C  Cerebral cortex

D  Medulla and brainstem

A  Doxapram

B  Caffeine

C  Theophylline

D  Aminophylline

A  32 mg

B  200 mg

C  40 mg

D  100 mg

A  To reduce blood pressure. To reduce blood glucose level.

B  To reduce uric acid levels. To reduce blood pressure

C  To increase the rate of respiration. To increase the depth of respiration

D  To reduce blood glucose level. To reduce uric acid levels.

A  Atomoxetine

B  Phentermine

C  Sumatriptan

D  Modafinil

A  Pulsating headache

B  Skeletal muscle weakness

C  Hyperactivity

D  High body mass index (BMI)

A  Narcolepsy

B  Attention-deficit/hyperactivity disorder

C  Postanesthetic respiratory depression

D  Migraine

A  Amphetamine

B  Phentermine

C  Orlistat

D  Atomoxetine